11th symposium on aplastic anemia and 9th symposium on myelodysplastic syndromes in children

Pediatrics International

Volumn 47, Issue 5, 2005, Pages 572-574

  Manabe, Atsushi ^a   Kojima, Seiji ^b  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTUPURINE; ANTINEOPLASTIC AGENT; CYTARABINE; ETOPOSIDE; FLUDARABINE; METOCLOPRAMIDE; MITOXANTRONE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; BLACKFAN DIAMOND ANEMIA; CHEMOTHERAPY; CHILDHOOD DISEASE; CONFERENCE PAPER; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE MYELOMONOCYTIC LEUKEMIA; MEDICAL PRACTICE; MYELODYSPLASTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROLACTIN RELEASE; QUALITY OF LIFE; RECURRENCE RISK; REMISSION; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ANEMIA, APLASTIC; CHILD; HUMANS; MYELODYSPLASTIC SYNDROMES;

EID: 29144451437     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02122.x     Document Type: Conference Paper

References (4)

1. Kojima S, Hibi S, Kosaka Y et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000; 96: 2049-54.
2. Abkowitz JL, Schaison G, Boulad F et al. Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis. Blood 2002; 100: 2687-91.
3. Sasaki H, Manabe A, Kojima S et al. MDS Committee of the Japanese Society of Pediatric Hematology, Japan. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 2001; 15: 1713-20.
4. Manabe A, Okamura J, Yumura-Yagi K et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group. Leukemia 2002; 16: 645-9.